Lipid transfer proteins (LTP) are considered to provoke plane pollen allergy, which frequently is associated with peach allergy. Aim of the study was the cDNA cloning of plane LTP Pla a 3, and to apply recombinant (r) Pla a 3 for molecular diagnosis in comparison to its natural (n) counterpart and peach LTP Pru p 3.
Birch (Betula) pollen is a major cause of allergy in northern and central Europe. e allergenic potency of products for diagnosis and therapy of birch pollen allergy is adjusted nearly exclusively to the major birch pollen allergen Bet v 1. However, many patients have also speci c IgE-antibodies against minor birch pollen allergens like Bet v 4, Bet v 6 and Bet v 7. e content of these minor allergens is currently not controlled in birch allergen products and their clinical relevance remains undetermined.
We developed and validated ELISAs for quanti cation of Bet v 4, Bet v 6, and Bet v 7 and determined these allergens in birch pollen allergen products from di erent manufacturers (prick test solutions [PTS] , products for sublingual [SLIT] and subcutaneous immunotherapy [SCIT] ). e results were also analysed in relation to allergenic activity, Bet v 1 and total protein content as laid down in the Monograph on Allergen Products in the European Pharmacopoeia.
All assessed products complied with their respective specications for these parameters. Moreover, we could detect all three minor allergens in each of the assessed products. However, their concentration was highly variable when comparing di erent products and manufacturers and even in several batches of the same product (PTS, SLIT and SCIT products alike). While allergenic activity, Bet v 1 and total protein content were clearly interdependent, none of the minor allergens showed a similarly strong correlation with these factors. Without adaptations to the current manufacturing processes, it therefore seems unfeasible to standardize birch allergen products also to minor allergens. Nevertheless, a future combination of data on minor allergen content in di erent birch allergen products on the one hand and clinical observations in birch pollen allergic subjects on the other hand could clarify the clinical relevance of minor allergens.
Chitin is an important cell wall component of Aspergillus fumigatus spores of which hundreds are inhaled on a daily basis. Chitin is not a structure of human cells, but humans have chitinases. Elevated chitinase levels in serum were found in asthma patients, and chitin induces accumulation of immune cells associated with allergy. Previous studies have shown that chitin has both anti-and pro-in ammatory properties; however the exact mechanisms determining the inammatory signature of chitin are poorly understood. We investigated the stimulation signatures induced in human peripheral blood mononuclear cells (PBMCs) by chitin in the presence or absence of human serum. Cytokines were measured in the cell culture supernatant by ELISA. Chitin showed an anti-in ammatory signature characterized by the production of IL-1Ra, which was dependent on opsonisation by immunoglobulins, internalization, and PI3K/Akt activation. In contrast, proin ammatory cytokines and IL-10 were not induced by chitin. Depletion of immunoglobulins and blocking the phagocytosis with cytochalasin D resulted in decreased IL-1Ra induction, while IL-1β production was increased. Heat inactivation of Ig depleted serum reduced IL-1β production suggesting a complement dependent pathway. Co-stimulation of chitin with non-fungal pattern recognition ligands (LPS, P3Cys or MDP) had synergistic e ects on the induction of pro-in ammatory cytokines. We conclude that chitin can have pro-and anti-in ammatory properties, depending on the presence of PAMPs and immunoglobulins during the stimulation. We hypothesize that human chitinases degrade chitin into small oligosaccharides to prevent the host from exaggerated pro-in ammatory responses to inhaled A. fumigatus conidia.
V06
Glutaraldehyde-modi ed birch pollen allergoid reveals high stability to endolysosomal degradation by dendritic cells Background: Allergen-speci c immunotherapy (AIT) is the only causative treatment for immediate type allergies. During AIT side e ects like anaphylactic reactions can occur. To improve the safety of AIT, chemically-modi ed allergen extracts, so called allergoids, have been introduced. Although allergoids are used in clinical practice routinely, immunological alterations are poorly described. Still, there are rst evidences that allergoid-induced tolerance might be mediated by di erent immunological mechanisms than AIT with native allergen extracts. Aim: We sought to determine the stimulatory capacity of allergoids in allergen-speci c T cell lines (TCL) and to assess their endolysosomal digestion by antigen presenting cells. Methods: Birch pollen (BP) allergoid was synthesized by glutaraldehyde (GA) modi cation and characterized in terms of molecular composition. In addition, binding of human BP-speci c IgE and a Bet v 1-speci c monoclonal antibody was investigated. BP-speci c TCL were generated from PBMC of BP-allergic patients and stimulated with GA-modi ed and non-modi ed BP extract as well as Bet v 1. Endolysosomal degradation of allergoid by antigen-presenting cells was analyzed in vitro using endolysosomal proteases isolated from the murine dendritic cell line JAWS II.
Results: GA-modi cation of BP extract led to a diverse highmolecular weight allergen polymer with strongly reduced antibody binding. Proliferation assays with BP-speci c TCL revealed decreased stimulatory capacity of the allergoid in comparison to native BP extract and Bet v 1. Of note, the allergoid was still stable a er 24h of degradation with endolysosomal extracts while the majority of Bet v 1 was degraded.
Conclusion:
Allergoids show reduced T cell stimulatory capacity compared to native allergen extract. While others have demonstrated retarded internalization of allergoids by dendritic cells, our data provide evidence that in addition their endolysosomal processing is delayed. Constitutive activation of the canonical wingless (WNT) pathway that induces high-level expression of ß-catenin target genes is a hallmark of many tumors. Several WNT inhibitors developed for cancer therapy are under clinical investigation.
Immune cells are regulated in terms of di erentiation and activation by the WNT pathway as well. Here we asked for potential e ects of WNT inhibitors on the acitvity of dendritic cells (DCs) as the major regulators of peripheral tolerance and immunity. For this, we employed mouse bone marrow-derived DCs (BMDCs). Treatment of unstimulated BMDCs with inhibitors that targeted ß-catenin resulted in moderate upregulation of MHCII and costimulators in a dose-dependent manner. However, their T cell stimulatory capacity remained una ected. In contrast, the inhibitor XAV-939, engineered to prevent cellular accumulation of ß-catenin by tankyrase inhibiton, yielded pronounced DC activation. Application of XAV-939 exerted no e ect on BMDCs stimulated with LPS. Ovalbumin-loaded DCs treated with XAV-939 promoted enhanced proliferation of antigenspeci c CD8+ (OT-I) and CD4+ (OT-II) T cells, and favoured production of 1/ 17-associated cytokines. Structurally different tankyrase inhibitors yielded similar results as obtained when using XAV-939. ese results suggest that tankyrases may serve to limit activation of DCs under basal conditions.
V08
KSRP constitutes an important posttranscriptional negative regulator of cytokine and chemokine production by activated dendritic cells Background: Although speci c immunotherapy represents an e ective treatment in many cases, success rates vary and patient compliance is low due to long treatment times. Our aim is to use an IL4-/IL-13 antagonist (IL-4 mutein) in combination with local application of adjuvants and allergens applying a biodegradable hydrogel to induce allergen-speci c systemic tolerance via generation of a tolerogenic microenvironment. Methods: e thermogelling PLGA-PEG-PLGA triblock copolymer-based hydrogel was generated by means of chemical synthesis. e characteristics of the hydrogel were analyzed by di erent methods. e IL-4 mutein was recombinantly produced and its functionality assessed by various T and B cell differentiation assays.
Results: e synthesized hydrogel showed the desired characteristics and was uid at room temperature and in a gelation state at body temperature. Additionally, the hydrogel was able to build a depot that is stable over several days in vivo. Moreover, the degradation of the gel in mice and the release of substances were visualized by magnetic resonance imaging (MRI).
e mouse IL-4 mutein was successfully produced using different recombinant expression systems and it´s functionality could be demonstrated by dose-dependent inhibition of IL-4-driven proliferation of the established cell line CTLL-2. Additionally, the IL-4 mutein was able to down regulate IL-4 induced proliferation and IgE class-switching of mouse spleen B cells. Moreover, IL-4 driven in vitro di erentiation of naive CD4+ T cells into TH2 cells was completely inhibited by addition of IL-4 mutein as analyzed by FACS. Conclusion: Taken together our results build the rst steps towards the combination of speci c immunotherapy and local T cell modulation applying adjuvant molecules to create a tolerogenic microenvironment. Moreover, the hydrogel together with di erent immune modulators builds a free combinable modular system that might help to shi immune balance under various pathological conditions.
V10
IPSE/alpha-1, a secreted glycoprotein from Schistosoma mansoni eggs, may inhibit in ammation Chronic infection with the parasitic worm Schistosoma mansoni is characterized by a strong anti-in ammatory immune response caused by schistosome eggs. Importantly, schistosome eggs secrete potent immunomodulatory molecules, including the glycoprotein IPSE/alpha-1. Previously, we have shown that IPSE/alpha-1 triggers basophils to release IL-4 and IL-13. ese cytokines are well known as key cytokines for 2 induction but also as inducers of wound-healing alternatively activated macrophages (AAMs). Moreover, in schistosome infection, IL-4 and IL-4 receptor signaling plays a crucial role in preventing excessive lethal intestinal in ammation in mice. is prompted us to investigate the anti-in ammatory potential of basophil-derived IL-4 following stimulation with IPSE/alpha-1.
When co-cultured with IPSE/alpha-1-stimulated basophils LPS-activated monocytes acquired an AAM-like phenotype with decreased production of pro-in ammatory cytokines IL-6, IL-1β and TNFα. Since immunohistochemical staining of infected murine gut reveals the presence of basophils in schistosome egg granulomas, we propose that IPSE/alpha-1-triggered basophil IL-4 turns down and controls schistosome egg-induced in ammatory processes. We expect that these ndings may be translated to new strategies for treating chronic in ammations such as allergy and autoimmune diseases. Infection with the parasitic trematode Schistosoma mansoni protects mice against allergic airway in ammation. It was reported that regulatory B cells (Bregs) are involved in this process. However, the mechanism of Breg induction is largely unknown. Previously, we have identi ed a glycoprotein secreted from S. mansoni eggs, IPSE/alpha-1, that triggers the release of IL-4 and IL-13 from basophils via interaction with surface IgE. Here we show that IPSE/alpha-1 is an immunoglobulin-binding factor that binds to isolated human CD19+ B cells presumably via the B-cell receptor (BCR) as the binding can be blocked by anti-IgG/M antibodies. Confocal microscopy revealed that IPSE/alpha-1 is taken up by the B cells and accumulates to a con ned area near the nucleus. Preliminary determination of the cytokine production and surface marker expression did not show a characteristic pro le described for Bregs. Nevertheless, its uptake and its circumscript perinuclear location suggest that IPSE/alpha-1 has an impact on B cell function. 
V12
Human IgE is e ciently produced in biologically active form in lepidopteran cells Euroimmun AG, Lübeck, Deutschland; 3 University Medical Center Freiburg, Deutschland e role of speci c and high a nity IgE in reacting against minute amounts of allergens and parasites and to provoke severe anaphylactic reactions renders IgE a mechanistically outstanding isotype. IgE represents the least abundant serum antibody isotype and exhibits a variety of peculiarities regarding structure and effector functions. Despite large progress in antibody technologies however the recombinant access to isotypes more complex than IgG still is scarce, a consequence of the demands of the immunoglobulins and the capacity of the expression systems used.
In order to overcome the limitations o en posed by mammalian expression systems we established the recombinant production of IgE in insect cells. Recombinant human IgE (rIgE) was e ciently assembled and secreted into the supernatant in yields of >30 mg/L. Puri cation from serum free medium using di erent means provided large amounts of rIgE. e rIgE exhibited a highly speci c interaction with its antigen, therapeutic anti-IgE and its high a nity receptor, the FcεRI. Lectins and glycoproteomic analysis revealed the presence of a prototypic N-glycosylation of the epsilon heavy chain. Mediator release assays demonstrated the biological activity of the IgE in activating e ector cells in response to trace amounts of antigen. In summary the expression in lepidopteran cells provide molecular access to IgE of retained characteristics and biological activity. Our data also contribute to the understanding and potential use of this important antibody isotype.
V13
Generation of speci c Fab antibodies for functional and structural analyses Background: erapeutic monoclonal antibodies are novel types of drugs with high bene t for patients but also new side e ects during therapy. ere is increasing evidence that biologicals can induce IgE-mediated allergic reactions like exanthema, urticaria and anaphylaxis. So far, little is known about the allergenic/immunogenic epitopes on biologicals and their characteristics. ere are clinical cases where fatal anaphylaxis was observed during the application of the biological cetuximab, associated with IgE to the disaccharide α-GAL. ese severe side e ects in general lead to a discontinuation of the treatment and/or the switch to another type of therapeutic antibody. However, the therapy switch is not always safe and successful. Methods: In our study, sera from patients treated with TNF-α-binding biologicals were evaluated positive for anti-biological antibodies by ELISA in routine clinical laboratory tests (IPM Biotech). ese anti-biological-Ig-containing sera were analysed in terms of anti-biological IgE via immunoblot with different biologicals such as in iximab, adalimumab and cetuximab as target antigens. To identify the epitopes on these biologicals, oligopeptide microarray analysis was performed with overlapping peptide epitopes from the biologicals and the corresponding ELISA-positive patient sera. Results: ELISA analyses show that sera from patients treated with anti-TNF-α biologicals contain antibody levels against these biologicals between 2 and 80 µg/ml. In iximab-positive sera tested in an adalimumab-ELISA were evaluated negative, showing that there is no cross-reactivity as determined by ELI-SA. In an oligopeptide microarray epitope mapping approach of in iximab-positive patient sera, distinct epitopes were identi ed in the variable, antigen-binding region of the biologicals. Conclusion: Taken together, these analyses shall lead to a knowledge-based allergenicity and side e ect risk assessment of each type of biological and to a safer recommendation of a therapy switch. Our immunologic knowledge is mainly based on analyses of human immune cells in vitro or on in vivo investigations in mouse models. However, complex biological processes are often species-speci c and di erences between mice and man limit the prognostic value in preclinical testing of novel biologicals for treatment of allergy, psoriasis or autoimmune diseases. Humanized mice have been developed to overcome these limitations. ey are immunode cient and allow the transplant of human tissues, patient-derived immune cells or blood stem cells (HSC) . Analysis of such humanized mouse models is used for preclinical testing of biological drugs leading to identi cation of functional mechanisms and important side e ects [Kubach et al. Int J Cancer. 2014 ,doi: 10.1002 ]. Here we demonstrate the preclinical analysis of the HIV-1 glycoprotein gp120 as an e cient polyclonal Treg stimulator that blocks overwhelming T cell activities in vitro and in vivo. Gp120 activates human Treg by binding and signaling through CD4, leading to accumulation of cyclic adenosine monophosphate (cAMP) in their cytosol and functional activation of suppressive capacity. Utilization of gp120 in a xenogenic humanized mouse model a single treatment with gp120 inhibits strong inammation of skin, liver and colon a er transfer of human immune cells. erefore, we are currently developing novel humanized mouse systems for e ective preclinical testing of immunotherapeutic concepts in order to evaluate the impact of novel biologicals on the restoration of the immunological homeostasis. ese models allow analysis of patient-derived immune cells in vivo and can be a helpful tool to evaluate the reasons but also feasible therapies of dysregulated immune responses observed in asthma, allergy and autoimmune diseases.
V16
The role of tonsillar epithelial E-Cadherin for the control of regulatory T cells in allergic children All inhalative or oral allergens have to pass the tonsils in the pharynx. Interestingly, the role of tonsils in the development of allergies or in the tolerance of allergens is not well investigated, even if there is no question about the tonsils' role as rstline defense barrier. In human tonsils but also in other organs Foxp3+ regulatory T cells (Treg) have been identi ed as significantly involved in the development of tolerance and in the formation of immune balance. Recently, there is increasing interest in the role of Treg subgroups for the control of di erent forms of in ammation and infection and former 2-transcription factor GATA3 seems to play an important role also in Treg. Moreover, there is a rising focus on the crosstalk of non-immune cells with immune cells becomes. One molecule of special interest is the adhesion molecule E-Cadherin which is widespread in all mucosal tissues like the airways or the intestine but can also be found in human tonsills and Allergens can attack epithelial barriers by breaking homologous E-Cadherin structures. E-Cadherin has two signaling partners on immune cells, KLRG1 and CD103 which are also expressed on Treg. We could show in a mouse model where intestinal N-Cadherin substitutes for E-Cadherin that KLRG1-E-Cadherin signaling is decisive in two directions: both the lack of E-Cadherin on intestinal epithelial cells and the KLRG1-knockout on all cells lead to the accumulation of Treg. In the current project we now want to dissect the importance of epithelial E-Cadherin for tolerance induction by priming Treg in pediatric tonsils and compare the data of allergic and non-allergic children. Moreover, the role of Treg subgroups like GATA3+-Treg in the protection of allergy pathogenesis is a special focus of this project. Initially developed to support translational tumor research biomaterial banks are well-recognized platforms to accomplish scienti c approaches in nearly all elds of medical research. Biobanks contribute to clinical and basic investigations by providing mainly human liquid and solid biospecimens and their derivates (nucleic acids, puri ed cells, supernatants) that were obtained, processed and stored under standardized and quality-controlled conditions. By o ering well-protected donorspeci c data sets, biobanks contribute to a better understanding of disease development and to personalized medicine approaches that aim to improve therapy on the patient level.
While well-advanced in tumor research biobanks are still in the early stage of development in allergy research. is is remarkable as translational research is an emerging eld of research in allergology. One step forward, inclusion of biospecimes obtained from other chronic in ammatory diseases might pave the way towards a better understanding of basic mechnisms that contribute to an imbalanced immune response and following autoimmune or allergic conditions. CBBM is a core facility of the medical faculty and all clinical settings of the Marburg University Hospital are enroled to recruite donors for the Marburg Biobank. e Marburg Biobank was established to support the local research focus "Tumor and In ammation". Based on SOP(standard operation procedure)-guided protocols and accomplished by a LIMS(Laboratory information management system)-based data center, CBBM has developed a work process to built up tissue-, liquid specimenand cell banks to collect samples for the investigation of malignant as well as chronic in ammation conditions. Tissue samples as well as lavages are prepared to be processed and cryoconserved for further analyses on the candidate and the -omics-level. In addition, sets of body uids and blood cell populations were employed to later determine immune, metabolic, hormonal and (epi)genetic parameters in these samples.
Respiratory tract V18
Pollen-derived adenosine plays an important role in induction of ragweed allergy Background: Adenosine is an important metabolite, which plays a role in in ammation as well as in immune suppression and regulation. Furthermore it has recently been shown that adenosine is released from pollen grains, giving rise to speculations of its possible role in pollen-induced allergic reactions. Aim of the study was to evaluate the role of pollen-derived adenosine in allergic airway in ammation. Methods: Mice were instilled intranasally with ragweed extract or ragweed extract depleted of adenosine and allergic airway in ammation was evaluated. Furthermore, the e ect of adenosine-depletion was assessed separately for the sensitization or the elicitation phase. In vitro, migration of human eosinophils and neutrophils towards supernatants of ragweedstimulated bronchial epithelial cells was analyzed.
Results: Eleven instillations with the total ragweed extract led to strong cell in ltration into the bronchoalveolar lavage, impaired lung function parameters and a systemic 2 response. Depletion of adenosine from the total ragweed extract abrogated the ragweed-induced local and systemic 2 responses. As expected, adenosine supplementation in the adenosine-depleted ragweed extract reestablished the symptoms of allergic airway in ammation. Interestingly, pollenderived adenosine showed a protective role in the sensitization phase, while exacerbating the elicitation phase of the allergic airway response. In vitro, human eosinophils and neutrophils migrated towards supernatants of ragweed extract-stimulated bronchial epithelial cells only in the presence of adenosine. Conclusion: Pollen-derived adenosine is a critical factor in ragweed-pollen induced allergic airway in ammation. Future studies aim at therapeutic strategies to control these allergenindependent pathways.
V19
Airway surface dehydration is a novel risk factor for allergic airway in ammation Introduction: We have previously demonstrated that mice with airway speci c overexpression of the amiloride-sensitive epithelial Na+ channel (βENaC-Tg) and mice lacking the epithelial Cl-channel SLC26A9 su er from airway surface dehydration and airway mucus obstruction, which might be implicated in the pathogenesis of allergic airway disease (Anagnostopoulou et al., JCI 2012 and Mall et al., AmJRespirCritCare Med 2008) . Here, we hypothesized that airway surface dehydration and reduced mucociliary clearance may increase the susceptibility for allergic airway in ammation. Methods: Aspergillus fumigatus extract (Af) was applied by intratracheal instillations into juvenile βENaC-Tg mice or WT mice (C57BL/6) and BAL cell counts, IL-13 levels and airway hyperresponsiveness (AHR, by Flexivent lung function) were determined. Genetic deletion of the IL-4/IL13 receptor signal transducer STAT6 was introduced to ENaC-Tg mice to analyze the contribution of type 2 in ammation to the Af immune response. Furthermore, preventive treatment of βENaC-Tg mice and WT mice with amiloride was performed and BAL and IL-13 levels were determined. Results: Airway eosinophils and pulmonary IL-13 expression were signi cantly increased in Af-challenged compared to vehicle-treated βENaC-Tg mice. Airway hyperresponsiveness was elevated in βENaC-Tg mice and increased further in response to Af treatment. Genetic deletion of STAT6 abrogated Af-induced airway eosinophilia and IL-13 expression in ENaCTg mice. Preventive treatment with amiloride signi cantly reduced allergic in ammataion in both βENaC-Tg and WT mice. Conclusion: Collectively, our results indicate that airway surface dehydration is a risk factor for key pathologies in allergic airway disease. Amelioration of airway surface dehydration (i.e. by amiloride) might constitute a novel target for prevention and treatment of allergic airway disease. Acknowledgements: DFG (DFG MA 2081/3-2)
V20
In ammatory e ect of wheat alpha-amylase/trypsin inhibitors (ATIs) on murine allergic airway activation 2012) . ATIs are also present in gluten preparations and are implicated as additional pathogenic triggers of celiac disease (CD) and other autoimmune and in ammatory diseases.
Aim and methods:
We investigated the e ects of dietary ATIs on allergic airway in ammation. Female C57BL/6 mice on a gluten-free diet (GFD) were sensitised and challenged with ovalbulmined (OVA). Animals were divided in 5 groups: 1. continued with the GFD and mock-sensitised with PBS, 2. continued with the GFD and sensitised with OVA, 3. changed to a diet containing 25% gluten (containing amounts of ATIs equivalent to the human wheat based diet), 4. changed to a diet containing puri ed ATIs, and 5. changed to a diet containing 25% gluten de-enriched of ATIs. We measured invasive lung function, Background: e soluble Guanylyl Cyclases (sGC) are widely distributed nitric oxide (NO)-dependent cyclic guanosine 5´-monophosphate (cGMP)-generating enzymes which beside others regulate smooth muscle tone and exert anti-in ammatory e ects. sGCs are obligate heterodimers, composed of α and β subunits. e sGCα1β1 is the most prevailing form in the lung and its expression is downregulated in asthma. To date mainly local pharmacolocigal intervention of the sGC/cGMP signaling was performed to address its impact on bronchial hyperreactivity and in ammation. In this study we use α1sGC knock out mice in a chronic model of asthma to illuminate the isoform-speci c impact of sGCs on the pathology of asthma in the mouse. Background: IgE-production directed against facultative airway pathogens such as Staph. aureus, Pneumococci, H. inuenza and Aspergillus species has been described in di erent chronic lung diseases. In the context of bronchial asthma, increases in pathogen-directed IgE titres accompany exacerbations of steady-state and have been associated with the development of IgE-production against classical allergens. Such associations are lacking for other chronic lung disease where similar studies have not yet been performed. Hypothesis: Sensitization patterns against bacterial, fungal and classical allergens correlate in a disease-speci c manner with the development, chroni cation and exacerbation of different chronic in ammatory lung diseases and in uence the course of infections with facultative pathogenic organisms. Methods: IgE against Staph. aureus and E. coli were detected by immunoblotting, IgE against H. in uenza and Pneumococci were detected by DELFIA, IgE against 176classic allergens were assessed by an allergen chip. Sensitization (IgE and IgG) against Aspergillus were assessed via commercially available CAP-systems. Microbial colonization was assessed by standard microbiological culture techniques. Results: We collected sera from 35 patients with CF and increased total IgE levels. Analysis of our patient samples revealed very distinct sensitization patterns. Correlations between sensitization against classical allergens and pathogenspeci c IgE as well as microbial colonization status and clinical parameters were performed. Outlook: ese analyses will have to be extended to more patients, sequential measurements and other lung diseases. ey will provide insight into the complex interplay between microbial colonization and allergic sensitization and promise to identify allergen-speci c IgE production as easily accessible biomarkers for di erent chronic lung diseases.
V23
House dust mite-speci c sublingual immunotherapy prevents allergic in ammation development in mice Background: Sublingual immunotherapy (SLIT) is a diseasemodi ying treatment for respiratory allergies. Evidence regarding SLIT e cacy and its good safety pro le has made it an attractable treatment option also for allergic asthma. e majority of studies have focused on grass pollens; however, data regarding e cacy for other allergens, like house dust mite are now available. Nevertheless, the underlying immunological mechanisms still remain only partially understood. Objectives: To establish a house dust mite (HDM) SLIT model and investigate local immunological changes. Methods: Balb/c mice were i.n. sensitized/challenged with a HDM extract. HDM SLIT was performed in advance of (prophylactic) the induction of an allergic airway in ammation. Lung in ammation and airway hyperresponsiveness were assessed by bronchoalveolar lavage cell counts, lung histology and exivent measurement, respectively. Humoral and cellular immune responses were monitored in serum, lung and BALF by ELISA and FACS-analysis. Results: Prophylactic sublingual administration of HDM prevents the recruitment of leukocytes, (mainly eosinophils and neutrophils) and airway hyperresponsiveness (resistance) as well production of the TH2 cytokines IL-5 and IL-13 in re-stimulated lymph nodes. No e ects on the immunoglobulin titer were observed. FACS-analysis of the lung T cell compartment revealed an involvement of CD4-CD8-γδ-T cells and CD8+CD25+IFN-γ+ cells in regard to the underlying mechanism. Conclusion: A clinical relevant HDM animal model may be useful to further elucidate the e cacy and mechanisms of HDM SLIT against asthma. Here we show that dextran-coated ferrous oxide nanoparticles (Fe-NPs) are opsonized by complement, which in turn facilitates speci c binding to B cells via complement receptors CR-1/2. In order to exploit their intrinsic B cell targeting property for the induction of an antigen-speci c antibody response, Fe-NPs were coated with ovalbumine (OVA) as a model antigen and immunostimulatory CpG oligonucleotides (ODN). When injected into naive C57BL/6 mice, Fe-NPs elicited a robust 1-biased antibody response as re ected by high IgG2a and concomittantly low IgG1 serum levels. In therapeutic OVAdependent anaphylaxis and asthma models, only particles conjugated with OVA and CpG inhibited IgE production, attenua ted bronchial hyper responsiveness and lung in ammation (asthma), and promoted survival (anaphylaxis).
V24
To the best of our knowledge this report is the rst to demonstrate B cell speci c targeting of a nanoparticle in a serumdependent manner and serve as nanomedicines for the treatment of infections and other diseases which require the induction of a strong humoral immune response.
V25
Potential anti-in ammatory and anti-viral e ects of Petasites hybridus (butterbur extract) on primary human nasal epithelial cells in vitro Background: As integral part of the innate immune system, nasal epithelial cells are involved in early steps of allergic inammation and defence against respiratory infections. A CO 2 extract of butterbur leaves (Tesalin) has been clinically shown to improve congestion in allergic rhinitis and reduce IL8 secretion, however the mode of action remains unclear. Aim of study: To evaluate the anti-in ammatory e ect of butterbur leaf extract for potential topical application in allergic and non-allergic, acute rhinitis/rhinosinusitis and to elucidate its mechanism of action in nasal epithelial cells. Methods: Human primary nasal epithelial cells were obtained from turbinoplastic surgeries. Cells were stimulated with the viral mimicks (PolyIC:TLR3, PolyIC-LyoVec:RIG-1/MDA5, CpG:TLR9), bacterial TLR ligands (Pam 3 CSK4:TLR1/2, Flaggellin: TLR5). Stimulation occurred either alone or in combination with Tesalin. Readouts were production pro-in ammatory cytokines and chemokines (IL8, GCSF, CCL3, CCL4, CCL5, CXCL10, IL6, TNFa, IL1a) and neutrophil chemotaxis towards stimulated supernatants. Results: Stimulation of human nasal epithelial cells with the TLR3 ligand PolyIC leads to the release of proin ammatory cytokines and chemokines and induced neutrophil chemotaxis towards cell supernatants. Tesalin reduced the PolyIC-induced production of proin ammatory cytokines and chemokines. Reduction of IL8 was paralleled by signi cantly decreased neutrophil chemotaxis towards supernatants of PolyIC/Tesalintreated cells. In addition, Tesalin in uences the regulation of RIG-1/MDA5, TLR9 and TLR3, but not TLR1/2 and TLR5, when stimulated with the di erent ligands of these receptors. Conclusion: Besides its clinical bene t in allergic rhinitis, our data imply that Tesalin might be an e ective treatment for nonallergic rhinitis and rhinosinusitis. Of note, Tesalin seems to speci cally target virally triggered pathways in human nasal epithelial cells, suggesting potent anti-viral potential of the herbal drug in topic application. We could previously show that overexpression of lung speci c Wnt-1 attenuates experimental allergic airway disease (Reuter, JI, 2014) . is e ect seemed to be independent of regulatory T cells (Treg) or IL-10 but was linked to the suppression of DC migration and there capacity to activate T cells in vivo and in vitro. e aim of this study was to investigate Wnt-1 as a treatment option for allergic airway disease. Method: C57BL/6 mice were sensitized intraperitoneally with Ovalbumin/Aluminium hydroxide on days 0 and 14. For induction of allergic airway disease mice were challenged via the airways by nebulization with a 1% OVA solution on days 28-30. Some mice received intranasal Wnt-1 treatment one hour prior to allergen challenge. At day 32 airway in ammation was quanti ed by measurement of lung function, lung histological staining, ow cytometry of lung and draining lymph nodes and analysis of cytokine secretion of restimulated cells.
Results: e application of Wnt-1 leads to a signi cant reduction of airway hyperresponsiveness, in ammation and goblet cell metaplasia. Changes of Treg cells were not detectable in the lung and lymph nodes. Furthermore, the number of DC remains equally, but the ratio of subtypes changed to a more Ly6C-CD11b-CD103+ phenotype. Hence, the activation of the β-catenin signaling pathway by intranasal application of Wnt-1 leads to a Regulatory T cells (Treg) play a critical role for maintenance of peripheral immunologic tolerance. Ine cient Treg function is associated with the development of allergic diseases. To restore the immunological balance in patients with allergy, we are developing biological drugs for functional activation of endogenous Treg. We have shown that human Treg can be activated by a polyclonal CD4-mediated mechanism, without a ecting the activity of CD4+ T helper cells. One candidate (BT-061/ Tregalizumab) is now in clinical trials (psoriasis, rheumatoid arthritis). A second promising candidate is HIV-1 envelope protein gp120 which we are developing for clinical application. We have shown, that gp120 activates polyclonally human Treg and e ciently inhibits the in ammatory symptoms of asthma in a humanized mouse model of allergic asthma (Martin et al. JACI.). However, this e ect was Treg-dependent as gp120 did not a ect the immunological reaction in the absence of Treg. Treatment with gp120 prior to challenge reduced in ltration of human immune cell into the lung tissue and abrogated the development of airway hyperresponsiveness.
Since patients with allergic diseases are treated with standard medications, that have the risk of adverse reactions and sometimes show reduced e cacy, the use of biological drugs for induction of Treg-mediated tolerance is a more e cient approach. In addition, not only the successful treatment of established allergy but also the development of a prophylactic approaches is of great importance. Here we already could show that next to the therapeutic bene t, the application of gp120 represents a prophylactic approach as well.
Next to the treatment of allergic airway in ammation other autoimmune disorders like psoriasis and rheumatoid arthritis are potential indications. Furthermore, gp120 would encounter a great unmet medical need in the eld of the prevention of transplant rejection. 
V28 GARP reduces allergic airway in ammation in

Glycoprotein A repetitions predominant (GARP) is an activation marker on the surface of human regulatory T cells (Treg).
We have recently shown that a soluble derivate (sGARP) has strong anti-in ammatory and regulatory properties in vitro as well as in vivo (Hahn, Blood, 2013) . sGARP represses proliferation and cytokine production of naïve and resting CD4+ T helper cells and induces CD4+ Treg. Furthermore, sGARP prevents in ammation in a preclinical in vivo humanized mouse model of gra versus host disease (GvHD). Because modulation of Treg responses could also have therapeutic e ects in other in ammatory diseases, aim of this study was to investigate the impact of sGARP in treatment of allergic airway diseases using a humanized mouse model (Martin, JACI, 2012) . To address this question, adult NOD/Scid γc-/-mice received peripheral blood mononuclear cells (PBMC) from a birch pollen allergy su erer.
To analyze the e ects of sGARP, additionally Treg alone or in combination with sGARP were transferred into the animals. Twenty days following cell application the allergic airway disease was induced by a three-day intranasal challenge with birch pollen allergen. 48 hours a er last challenge allergic in ammation was assessed by measurement of airway hyperresponsiveness (AHR), quanti cation of cells in the bronchoalveolar lavage (BAL) and analysis of human immune cells in di erent tissues by ow cytometric and histological staining.
In comparison to mice that received Treg alone, additional transfer with sGARP signi cantly reduced AHR, total human immune cell counts, neutrophils and macrophages in the BAL and human CD4+ T cells in the lungs. Furthermore, number of mucus producing goblet cells was reduced upon sGARP injection. Hence, amplifying of Treg cell function via sGARP seems to be a promising treatment option for allergic airway diseases. We have previously shown that a 2-polarized airway in ammation can facilitate priming to new antigens in the lungs which we call "collateral priming". To investigate whether an allergic skin in ammation can also facilitate priming towards new antigens, we established an murine allergic skin in ammation model in analogy to an allergic lung in ammation model.
Skin
Mice were sensitized intraperitoneally towards ovalbumin as primary antigen. Challenge was performed intranasally or epicutaneously with ovalbumin (OVA) and a secondary antigen, keyhole limpet hemocyanine (KLH). Re-challenge consisted of local application of either antigen alone. Analysis of KLH-speci c antibody responses, KLH-speci c cytokines by means of ELISA and local in ammation demonstrated tolerance induction towards the secondary antigen in the skin, whereas in the lung priming took place. Flow cytometric analysis revealed increased numbers of Tregs, increased CTLA-4 expression and an enhanced suppressive capacity of Tregs from skin-draining lymph nodes compared to Tregs from the lungdraining lymph nodes.
ese results demonstrate crucial local di erences in Treg function in skin vs. lungs upon repetitive antigen contact which decisively shape the immune response towards new antigens. We present the case of a 10-year old boy who su ered a serious episode of an anaphylactic reaction a er topical application of an herbal ointment (Kytta Salbe). is ointment was applied for aching muscles on the back. Only a few minutes a er application he developed an urticarial skin reaction on the whole back attended and followed by abdominal pain, generalized urticaria, shivering, numbness, dyspnea and twitching of the eyelids. Emergency treatment with corticosteroids and antihistamins led to complete remission of the symptoms within two days. Skin prick testing with single ingredients of the ointment provided by the manufacturer showed urticarial reaction against the whole ointment and its ingredient phenonip. All other single ingredients were negative. Additional testing of parabens and further preservatives was completely negative. Skin prick testing with grass, tree and herbal pollen and with house dust mites and cat epithelia was negative as well. Phenonip is a broad spectrum antimicrobial agent comprising a synergistic blend of esters of para-hydroxybenzoic acid (parabens) in phenoxyethanol designed for preservation of a wide range of cosmetics and toiletries. Furthermore, it can frequently be found in ink pens and in medical vaccines. Usually allergic reactions against phenonip or its components phenoxyethanol and parabens are late type allergies that results in allergic contact eczema. is is one of the rare cases in which phenoxyethanol led to the development of contact urticaria followed by a systemic anaphylactic reaction. To our knowledge only three cases have been published so far. It must remain unclear what product led to the acquirement of the sensitization against phenonip, as this ointment had been applied for the rst time. Possibly, phenoxyethanol containing vaccines had been etiological. Immunoglobulin E (IgE) plays a major role in the pathophysiology of atopic predisposition, although its role in atopic dermatitis (AD) is not fully understood. Anti-IgE treatment with omalizumab has become available and was approved for treating asthma and urticaria. However, application of omalizumab in patients with asthma and concomitant AD led to varying results on AD disease activity. Immunoadsorption (IA) has been used in AD using either speci c depletion of IgE and/or in combination with IgG adsorption. We now assessed the e ects of IgE-speci c IA (IgE-IA) on quality of life and disease activity in severe AD.
We analysed 4 patients that received IgE-IA. All of them su ered from severe AD with score-points ranging from 34 to 87 (SCORAD) and from 14 to 51 (EASI). Patients had received di erent treatments for AD before according to guideline recommendations without su cient control of disease. As add on therapy, all patients received 5 2-day treatment cycles of IgE-IA within 10 weeks every 2 weeks. IgE levels, disease activity (SCORAD/EASI) and quality of life (DLQI, wellbeing ve) were monitored before every IA.
All patients had highly elevated basal total serum IgE levels (range 1.352-23.553kU/l). e mean reduction of circulating IgE for all 5 cycles of all 4 patients was 85% (range 82-90%). However, within the treatment-free interval, IgE levels raised signi cantly again. Disease activity a er all 5 cycles was strongly reduced in all 4 patients (mean 48%, range 27-66% as assessed by SCORAD, and mean 80%, range 69-89% in EASI). In line, the quality of life was improved by 55% (DLQI, range 21-71%) and by 81% (wellbeing ve, range 17-200%).
In summary, our preliminary results in a small patient collective prove a reliable and dramatic reduction of the total IgE level in serum during IA associated with reduction of disease activity and improvement of the quality of live. Despite disappointing results of anti-IgE treatment in AD, IgE-IA might be highly bene cial for patients with severe AD
V32
Proteomic patterns in chronic hand eczema Background: Chronic hand eczema (CHE) is a frequent skin disease and has a high socio-economic impact. Pathogenesis of CHE is multifactorial and depends on exogenous factors such as chronic irritant damage or contact allergy and on endogenous factors such as an atopic predisposition. In many patients, however, factors triggering the eczema cannot be clearly identi ed, or potential triggers cannot explain the clinical presentation. Objectives: Pathogenetic processes are o en re ected by variations in protein expression. Little is known about protein expression patterns in the skin of patients with CHE. We therefore set out to systematically and comprehensively analyze the di erential protein expression in CHE using modern mass spectrometry. Methods: We analyzed palmar skin from hand eczema patients and healthy volunteers by performing LC-MS/MS analyses and label-free quanti cation. Subsequently, results were con rmed by immunohistochemistry of palmar skin from a separate cohort. Results: In total, we were able to identify 185 candidate proteins that were signi cantly di erentially expressed in the CHE samples. A detailed analysis of the mass spectrometric results revealed a characteristic proteomic pattern of epidermal barrier components and keratinocyte di erentiation in CHE. Immunohistochemistry con rmed these ndings. Conclusions: Our results provide important clues to molecular factors and signaling pathways involved in the pathogenesis of chronic hand eczema. Background: Innate lymphoid cells (ILCs) can be classi ed into three groups based on their dependency on transcription factors and expression of cytokines. e role of ILCs in the e ector phase of allergic contact dermatitis has not been addressed so far. We have identi ed all groups of ILCs in ear skin, skindraining lymph nodes (SDLN), blood and spleen of wild type mice. Using the contact hypersensitivity (CHS) mouse model we demonstrated that NK cell-and ILC2 numbers increase in the ear skin 24 h a er sensitization and elicitation of CHS with the contact allergen TNCB. Dermal ILC2 show an activated phenotype. Aim: We want to evaluate the functional relevance of ILCs in both phases of CHS using targeted antibody depletion of ILCs and an adoptive transfer model. Methods: For depletion of ILCs T-cell de cient Rag1-/-mice (CD90.2 genotype) were treated i.p. 4x with a CD90.2 speci c monoclonal antibody. For adoptive transfer naïve donor mice (CD90.1 genotype) were sensitized with TNCB. A er 5 days T-cells were FACS-sorted from SDLN and adoptively transferred i.v. in Rag1-/-mice (CD90.2 genotype). A er transfer mice were challenged with TNCB on the ear skin and e ective transfer of the CHS reaction was measured by increase in ear thickness. Results: ILCs were e ciently depleted in the blood, spleen and SDLN using the above mentioned depletion protocol. Transfer of total lymph node cells or sorted T-cells into RAG1-/-mice was successful and signi cant hapten-induced ear swelling could be detected time dependent a er the hapten challenge regardless of whether T cells were transferred one hour or three weeks prior to the challenge. Transferred lymph node cells showed hapten-speci c proliferation in vitro. Outlook: Given the e cient antibody mediated depletion of ILCs and the successful adoptive transfer of the hapten speci c CHS in RAG1-/-mice, this approach should now allow us to address the functional role of ILCs during the elicitation phase of CHS.
V34
Mouse models of chemically induced scleroderma show di erences in early skin in ltration e cellular and molecular events resulting in brosis development in scleroderma patients are not fully understood. While a multitude of data have been reported in terms of T cell and mast cell activation in the late phase of tissue brosis, the speci c contribution of antigen presenting cells like dendritic cells and macrophages in the early phase of brosis induction remains unaddressed. For induction of brosis bleomycin and HOCL were administered s.c. in the neck area every day and skin punches were analyzed for quanti cation of skin thickness, collagen deposition, myo broblast activation (α-SMA), in ammatory in ltrate (HE, ow cytometry) and for expression of in ammation and brosis related mediators (qRT-PCR).
At day 28 both models resulted in a signi cant increase in dermal thickness, total collagen levels and a prominent appearance of collagen bers compared to PBS-treated control animals. Mice injected with HOCl exhibited the most prominent skin thickness vs. the bleomycin-treated animals which was accompanied by a thick layer of subdermal fat in the HOCl-group. Histological analysis revealed an increase in cellular in ltrates in both Scl models which were characterized by using 7-color ow cytometry for DC and macrophage markers.
In ltrates peaked at day 7 in bleomycin-/ HOCl-treated skin, decreased and were absent at day 28 of continuous bleomycin or HOCl application. ere was a signi cant increase in the number and percentage of CD11b+MHCII+ cells in the HOClmodel which points to an activated antigen presenting myeloid cell population. In addition, the percentage of CD11c+MHCII+ representing mostly DC and of Ly6C+MHCII+ and F4/80+MHCII+ monocytes/ macrophages was signi cantly elevated in the skin of HOCl-injected animals. In both models, we found upregulated pro brotic parameters with a prominent induction of procollagen α1(I) in HOCl-and preferential development of α-SMA in bleomycin-treated mice. ere are a number of pathologic conditions where immune complex (IC) deposition causes Fc receptor-dependent in ammatory lesions, such as lupus nephritis or cutaneous vasculitis. 6-sulfo LacNAc dendritic cells (slanDCs) are equipped with a unique capacity to bind IC via the two IC receptors CD16 and CD32. slanDCs circulate in blood at high numbers, have an outstanding capacity to produce IL-12, IL-23, TNF-α and IL-1β, and can be found as in ammatory dermal DC in psoriasis and lupus erythematosus (LE).
In this study we provide strong evidence for the molecular and functional specialization of slanDCs as proin ammatory cells in LE-nephritis and cutaneous vasculitis. Histological studies revealed a strong accumulation of slanDCs in lesions with dense IC deposition, e.g. in the glomerulus from LE-nephritis patients and in the intra-/perivascular areas from cutaneous vasculitis patients.
To investigate the ICs-mediated slanDCs recruitment capacity, we applied a perfusion assay-based approach coupled with time-lapse video microscopy and measured the arrest functions of puri ed leukocyte subtypes on immobilized ICs. e ow conditions were adjusted to provide physiologically relevant surface shear stress of human venous capillaries. Under these conditions we observed a pronounced recruitment of FcγRIII (CD16) positive slanDCs which was completely dependent on CD16.
In a translational in vivo approach, immunode cient Nonobese diabetic (NOD)-SCID interleukin-2 gamma chain receptor (NSG) mice were intravenously injected with preformed ICs and subsequently with uorescent labeled slanDCs. Using Fc receptors blocking monoclonal antibodies, we show that glomerular deposition of ICs mediates recruitment of human slanDCs in a CD16-dependent manner.
Collectively, our ndings demonstrate the IC capacity to recruit circulating slanDCs in vitro and in vivo. Modulation of ICs-mediated slanDCs recruitment may o er therapeutic bene ts in patients with IC-mediated in ammatory and/or autoimmune diseases. We report the case of a 43-year old female who developed two episodes of anaphylactic reactions a er consumption of a breakfast including milk, oatmeal, fresh apples, strawberries and amaranth. She was eating breakfast in this composition for several months. In both cases she developed generalized urticaria, dyspnea and circulatory collapse within several minutes a er meal. Emergency treatment with corticosteroids and antihistamins led to complete remission of symptoms within two hours. Her medical history was negative for any allergic reaction, she was not su ering from hayfever or asthma. ere was no history of atopic eczema. Skin prick testing showed reactions to tree, grass and herbal pollen and amaranth. Prick testing with other ingredients of the cereal was completely negative. Serological investigation showed normal values for total IgE and basal serum tryptase. Slightly raised speci c IgE antibodies could be detected against grass, tree and herbal pollen. No speci c IgE was found for milk, rye, wheat, millet, rice, buckwheat, sesame, apple and strawberry. Amaranth is a cosmopolitan genus of annual or short-lived perennial plants. Some amaranth species are cultivated as leaf vegetables, cereals, and ornamental plants. To this day, amaranth grains are toasted much like popcorn and mixed with honey, molasses or chocolate or are added in cereal mixtures. In 2013 the rst case of an anaphylactic reaction a er consumption of amaranth grains has been published. is allergy therefore seems to be very rare. ere seems to be no cross-reaction of amaranth seed extract and pollen, however knowledge concerning this allergy is limited. Furthermore, there is a multiplicity of amaranth species with a di erent composition of possible allergens. As the addition of amaranth to di erent cereals is increasing as a kind of fashion trend in nutrition, amaranth allergy should be kept in mind as a possible elicitor of anaphylaxis.
V37
Isolation and characterization of di erent peanut oleosins: New tools for component-resolved diagnosis of peanut allergy.
cades. e tight association between serious allergic symptoms and the presence of a class of lipophilic proteins, called oleosins, has been clearly shown for several oil-rich plants, but not for peanut. Since allergy diagnostic testing is based on aqueous extracts, potential allergenic proteins of lipophilic nature are usually underrepresented or even absent. To close the existing detection gap in the established peanut allergy diagnostics, our study focused on the isolation, molecular characterization and assessment of the allergenicity of peanut oleosins. Methods: A comprehensive method for the isolation of oleosins was developed. is method comprised a step by step removal of seed storage proteins from peanut oleosins. Oleosin separation was carried out by preparative electrophoresis. Subsequent N-terminal sequencing, peptide mass ngerprinting and homology search were used for the identi cation of oleosins. Evaluation of the IgE-binding capacity was conducted by immunoblot analysis with sera of peanut-allergic individuals. Results: Highly puri ed oleosins were isolated from the complex lipophilic matrix of peanut. Further separation of the different oleosins was realized by a single run on an electrophoresis cell. All known peanut oleosins were identi ed by mass spectrometry and N-terminal sequencing, including the allergens Ara h 10, Ara h 11, the presumed allergen oleosin 3 and additional oleosins variants. Western blotting illustrated the allergenicity of these immunologically distinct oleosins. Conclusion: Our method provides a novel strategy to isolate all known peanut oleosins simultaneously. Furthermore, there is some evidence that oleosins are relevant allergens linked to a severe peanut allergy. Hence, oleosins are introduced as important candidates for the component-resolved diagnostic.
V38
Development of a sensitive and speci c sandwich-ELISA for the detection of the peanut marker allergen Ara h 2 in human breast milk Background: Peanut allergy is a severe food allergy which already occurs in early childhood, frequently on rst known oral exposure to peanuts. erefore, the transfer of allergens via breast milk is discussed as a possible sensitization route. In a Canadian study, peanut proteins have been identi ed in lactating women, but without further speci cation. In addition, another study showed the transfer of Ara h 6 into breast milk in 2 subjects. With regard to a possible sensitization via breast milk, our aim was to establish a sandwich-ELISA for the quanti cation of the peanut marker allergen Ara h 2. Methods: A German cohort of 40 lactating women without peanut allergy was established. A er a 24-hour legume-free diet, Ara h 2 levels were assessed in human breast milk before (as basal sample) and at di erent time points between 1 to 12 hours a er ingestion of 100 g roasted peanuts. In order to develop a sandwich-ELISA directed against Ara h 2 for the detection in human breast milk, antibody-matching, cross-reactivity analysis and bu er evaluation were performed using antiAra h 2 antibodies of di erent origins and di erent Ara h 2 epitope-speci city.
Results: e optimized sandwich-ELISA for Ara h 2 detection in breast milk has a detection limit of 2.5 ng/mL. Additionally, no cross-reactivity against Ara h 6 and other legume extracts was found. e intra-assay coe cient of variation (CV) was 4.1%, and the inter-assay CV was 12.6%. Using this ELISA, Ara h 2 was detected in breast milk samples from 16/40 subjects (range: 2.6 to 194 ng/mL). Conclusion: By means of a sandwich-ELISA, we established a sensitive and speci c diagnostic tool for the determination of Ara h 2 in human breast milk. us, we are able to show the transfer of the peanut marker allergen into breast milk of 40% of the lactating women. ese results are important with respect to an occult sensitization via breast milk and the implementation of prevention strategies for children at risk.
V39
The conformational IgE epitope pro le of soybean allergen Gly m 4 (Junker Y et al, J Exp Med 2012) . ATIs that are present even in "pure" gluten preparations are implicated also as promoters in the pathogenesis of celiac disease and possibly other autoimmune / in ammatory diseases. erefore, we studied the e ect of dietary Gluten/ATIs on intestinal in ammation. Methods and Results: C57BL/6 mice were set on a gluten-free diet (GFD) or (a usually gluten containing) standard-diet (STD) and subject to dextran sodium sulphate (DSS)-induced colitis (2.5% DSS in drinking water for 7-14 days). e GFD diet strongly reduced colonic in ammation compared to the STD. GFD fed mice maintained normal body weight, showed attenuated in ammation with reduced numbers of in ltrating inammatory cells in the colonic mucosa and lacked epithelial erosions. Transcript levels of pro-in ammatory cytokines such as IL-1β and IL-6 in the intestine were signi cantly down-regulated in colitic C57BL/6 mice kept on a gluten-free diet compared to mice fed the STD. Furthermore the mouse model of T cell transfers DSS-induced colitis in RAG1-/-mice indicated a T cell mediated response in dietary gluten was an important trigger of T cell mediated in ammation.. FACS analyses revealed that dietary (ATI-containing) gluten altered the balance of pro-in ammatory (IL-17, IFN-g) and anti-in ammatory (IL-10) cytokines in T cells of lymphoid compartments (spleen, mesenteric lymph nodes) and in the mucosa towards a proin ammatory state. DSS-induced severe colitis in mice fed the STD was accompanied by a shi towards a proin ammatory microbiota. Background: Dietary short chain galacto-and long chain fructo-oligosaccharides (scGOS/lcFOS) and TLR9 ligand CpG DNA a ect intestinal epithelial cell (IEC) function. Epithelial derived IL-1α is known to contribute to allergic sensitization in the lung. Aim: To study the e ect of IL-1α on 2 polarizing chemokine release by IEC and the modulatory e ect of scGOS/lcFOS and CpG DNA in presence or absence of monocyte derived dendritic cells (moDC). Methods: HT-29 cells (IEC) cultured in transwells were preincubated basolaterally with IL-1α± IFNγ/TNFα and apically with scGOS/lcFOS ± CpG DNA for 6 hours, washed and basolaterally exposed to immature moDC or medium while apically exposed to scGOS/lcFOS ± CpG for 24-48 hours. 2 driving IL-25, CCL2, CCL22 and regulatory galectin-9 and TGF were measured in basolateral supernatants. A er 48h of co-culture, moDC were added to allogenic naïve T-cells for 6 days (MLR) and cytokines were measured. Results: Combined IFNγ/TNFα activation induced the release of CCL2 and CCL22 by IEC, which was further enhanced by IL-1α. IFNγ/TNFα ± IL-1α activation also increased galectin-9 and TGF (24h). Exposure to scGOS/lcFOS ± CpG DNA reduced CCL2 and CCL22, while galectin-9 and TGF remained high. In the 48h supernatants of IEC/moDC co-cultures, scGOS/lcFOS enhanced galectin-9 in presence or absence of CpG DNA. scGOS/lcFOS plus CpG DNA reduced IL-25 in co-cultures pre-exposed to IFNγ/TNFβ/IL-1α while increasing IFNγ concentrations in the MLR. Conclusion: IL-1α enhances 2 polarizing chemokine release by IFNγ/TNFα activated IEC. Combined exposure to dietary scGOS/lcFOS plus CpG DNA suppresses this response skewing away from the allergic phenotype.
V41
is study was performed within the framework of Dutch Top Institute Pharma (T1.501).
V42 Administration of recombinant GARP inhibits allergeninduced colitis in a humanized mouse model of allergy
Previously, we could demonstrate that the inhibition of allergen-induced IgE-dependent gut in ammation in PBMC-engra ed immunode cient mice by regulatory T cells (Treg) was dependent on the Treg activation marker glycoprotein A repetitions predominant (GARP). Besides its role on the regulatory function of Treg, GARP has been shown to possess anti-in ammatory properties by enhancing Treg activity in vitro and in vivo. e aim of this study was to investigate whether GARP might be protective in our humanized mouse model of allergy, too. erefore, NOD-scid-γc-/-mice were injected intraperitoneally with human PBMC from allergic donors together with the respective allergen in the presence or absence of recombinant GARP or, for comparison, activated Treg of the same donor. A er an additional allergen boost one week later, mice were challenged with the allergen rectally on day 21 and gut inammation was monitored by a high resolution video mini-endoscopic system evaluating translucency, granularity, brin production, vascularity, and stool. Administration of GARP reduced the number of migrated CD45+ human cells in mice. Furthermore, an increased amount of FoxP3+ cells could be observed. Consequently, total and allergen-speci c human IgE production in mouse sera was almost as strongly inhibited in GARP-treated mice as shown for co-injection of activated Treg leading to a similar prevention of allergen-induced gut in ammation a er rectal allergen challenge. ese results demonstrate that activation of Treg by GARP may be an additional tool for therapeutic intervention of allergic diseases of the intestine. Background: Exposure to cat and dog allergens is considered as important risk factor for development of asthma and rhinitis. e prevalence of small furry animals seems to be increasing in households of industrialized countries, but epidemiological data on small animals and exposure in schools are still lacking. Methods: Questionnaires were distributed to 1761 pupils in three secondary schools in Luxembourg in order to record the prevalence of pets in families with children of school age. Electrostatic dust collectors were exposed for two weeks in representative classrooms with low to high pet prevalence. Additional dust collectors were exposed at 40 homes of children with and without pets. Dust samples were extracted and the marker allergens Can f 1, Fel d 1, Cav p 2 and Ory c 3 were quanti ed. Results: Total pet prevalence was 66%, 36% kept a dog, 31% a cat, 14% a rabbit, 4% a guinea-pig and 3% a hamster. 11% had at least once a week contact with horses and 8% were living on a farm. Can f 1 and Fel d 1 levels were signi cantly di erent between the three schools. Levels between classes with presence of many pet owners and few pet owners were variable and differences were not signi cant. No guinea-pig allergens could be detected, but low levels of rabbit allergen were present in some classrooms. Can f 1 levels measured in schools (median 55.3 ng/m 2 , range 0-533) reached values similar to those measured in homes of dog owners (median 253.8 ng/m 2 , range 0-2201). Fel d 1 was measured at comparable levels as Can f 1 in schools (median 69.7 ng/m 2 , range 0-457) and in homes of cat owners (median 117.3 ng/m 2 , range 0-2448).
Posters
Conclusion: e prevalence of pets in families of Luxembourgish school children is much higher than the European average. Allergen levels varied signi cantly between the 3 schools analysed. Levels of Can f 1 and Fel d 1 measured in some classes are comparable to values obtained in homes of pet owners and constitute a risk factor for allergic children. All over the world the occurrence of allergic diseases increased during the last decades. One major causative factor are airborne pollen grains of amenophilic plants, e. g. diverse grasses and trees. e allergenic potential of pollen depends on the amount of produced allergenic proteins (e.g. PALMs), which also seemed to be involved in the plant's defense mechanisms. Soil or air pollution could a ect the plant's capability to defense itself against contamination with microbes. Up to now little is known about the composition of microbial communities colonizing allergenic plants (or their reproductive organs like pollen grains) and in what extent this contamination might in uence the plant's production of allergenic proteins. In this study we grew pure cultures of cultivable microorganisms on di erent media isolated from pollen of timothy grass and birch. For identi cation we used comparative 16S-rDNA and ITS1-2 sequence analysis, respectively. We also applied T-RFLP ngerprint techniques, a culture independent method based on the ampli cation of the 16S-rRNA gen, to determine the composition of the microbial population on the pollen. Furthermore we did statistical correlation analysis of microbial contamination, several environmental parameters and the content of immune modulatory PALMs from pollen sampled on di erent locations as well as principal components analysis, analysis of similarity and cluster analysis.
P02
Microbial colonization of pollen and their contribution to allergy
So far a liated microbial isolates associated with pollen belong to Bacillus sp. and Pseudomonas sp., but also to phytopathogenic genera like Pantoea sp. or the phytotoxic fungy Fusarium sp. A er proving the reproducibility of the analytical microbiom-data, evidences of distinct colonizing patterns could be shown on di erent pollen species. e data were compared due to cultivable microbes from these pollens, the amount of produced immune-modulatory compounds (e.g. PGE2) as well as concerning the in uence of environmental parameters.
P03
Airway surface dehydration impairs pulmonary allergen clearance Introduction: E cient clearance of inhaled allergens from the lungs of patients with allergic asthma is important to avoid prolonged allergen exposure and asthma exacerbation. We hypothesized that impaired mucociliary clearance constitutes a risk factor for ine cient intrapulmonary allergen clearance. us, we analyzed allergen clearance mechanisms in wild type (WT) mice and in mice with airway-speci c overexpression of the sodium channel ENaC (βENaC-Tg), which su er from airway surface dehydration, impaired mucociliary clearance and chronic airway in ammation [Mall et al., Nat Med., 2004] . Methods: Mucociliary clearance was determined by intratracheal application of 1 µm uorescent beads and video-microscopic analysis of in vivo bead elimination. Following intrapulmonary application of uorescently labeled Aspergillus fumigatus extract (Af), total allergen clearance was analyzed by measurement of residual uorescence in lung homogenates a er designated time points. Bronchoalveolar lavage (BAL) from WT and βENaC-Tg mice was analyzed by ow cytometry to identify immune cell populations with Af uptake. Results: Mucociliary clearance and total lung allergen clearance were signi cantly reduced in βENaC Tg-mice compared to WT mice. Antigen-presenting cells including alveolar macro phages (AM) and conventional dendritic cells (cDCs) were identi ed as cell types with strongest Af uptake among immune airway cells. In addition to decreased total allergen clearance, βENaC-Tg mice showed reduced allergen uptake by AM when compared to WT mice. However, the level of allergen presenting airway cDCs was signi cantly elevated in βENaC-Tg mice. Conclusion: We conclude that airway surface dehydration impairs pulmonary allergen clearance. Hence, we suggest that ine cient allergen clearance might contribute to increased allergen presentation by cDCs which could constitute a risk factor for allergic sensitization during chronic airway in ammation.
Rationale:
We have previously demonstrated that mice with airway speci c overexpression of the epithelial Na+ channel (βENaC-Tg) exhibit airway surface dehydration and eosinophilic airway in ammation in juvenile mice (Mall MA, 2008) . We hypothesized that airway surface dehydration may increase the susceptibility for allergic airway in ammation and treatment with allergen could induce IL-13 expression in vivo. Here, we evaluated cellular sources of IL-13 expression in response to allergen treatment in wild-type and βENaC-Tg mice. Methods: Juvenile wild-type and βENaC-Tg mice were challenged intratracheally with Aspergillus fumigatus (Af) extract. In vitro restimulated whole lung-derived leukocytes were analyzed for IL-13 expression by multicolor ow cytometry. Laser microdissection (LMD) of the airway epithelium and subsequent nested qPCR were performed for quanti cation of airway-speci c mRNA expression of IL-13, IL-33, IL-25, TSLP and periostin. IL-13 expression was con rmed by immunohistochemistry with IL13-/-mice-derived lung tissue as negative control. Results: Intrapulmonary exposure of Af signi cantly increased airway eosinophils and pulmonary IL-13 in βENaC-Tg mice. We observed elevated numbers of pulmonary IL-13+-cells among macrophages, 2-, B-and ILC2-cells in βENaC-Tg mice by 11-color ow cytometry, which was further increased in response to Af treatment in 2-and ILC2-cell populations. LMD revealed airway epithelial cell-speci c expression of IL-13 and IL-33 but not TSLP and IL-25 in βENaC-Tg mice. Immunostaining con rmed epithelium-mediated IL-13 protein expression, which was enhanced a er Af challenge in βENaC-Tg mice. Conclusion: We demonstrate that airway surface dehydration is a risk factor for allergic airway in ammation including increased frequencies of IL-13+-cells in response to allergen. Expression of IL-13 is not limited to 2 cells, but also ILC2 cells and airway epithelium provide substantial amounts of IL-13 in vivo.
cho-alveolar lavage, systemic and local proliferative and 2 cytokine responses as well as allergen-speci c IgE in serum were analyzed. Results: Compared to the bu er-treated control group mice treated sublingually with allergen extract were refractory to the development of airway hyperresponsiveness, eosinophil attraction to broncho-alveolar lavage (BAL), allergen-speci c IgE in serum and systemic proliferative responses following allergen challenge. Conclusions: We could show that prophylactic sublingual treatment with allergen extract prevents the development of house dust mite induced allergic asthma in a mouse model. Clinical studies are required in order to determine whether this concept also holds true for humans.
